Assay News and Research

RSS

Highly sensitive ELISA method for analysis of CET in plasma samples

This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.

23 Feb 2018

3D Signatures reports positive results of new Telo-HL test for Hodgkin's lymphoma

3D Signatures Inc. is pleased to announce that a preliminary third-party analysis of the trial data for Telo-HL, 3DS' test in development for Hodgkin's lymphoma (HL), shows that the Company's TeloViewTM platform is able to distinguish, with a high degree of statistical significance, multiple differences between a patient group that responds to standard ABVD chemotherapy, and a group that relapses or is refractory to treatment within the first 12 months.

22 Feb 2018

Using Smartphones for Cancer Diagnosis and Management

Dr. Castro is a translational oncologist with experience developing and harnessing nanotechnology and molecular imaging platforms for cancer purposes. His work offers a “less is more” approach — to generate robust cancer analyses using scant amount of specimens. Dr. Castro’s research has included funding from the V Foundation for Cancer Research, National Institutes of Health, Ovarian Cancer Research Fund, and the Department of Defense.

From Pittcon 14 Feb 2018

Scientists develop new array to identify biomarkers for wide range of diseases

Scientists have developed a way to identify biomarkers for a wide range of diseases by assessing the antibodies we are making to the complex sugars coating our cells.

12 Feb 2018

NIH scientists modify new RT-QuIC assay to detect Parkinson's, dementia with Lewy bodies

National Institutes of Health scientists developing a rapid, practical test for the early diagnosis of prion diseases have modified the assay to offer the possibility of improving early diagnosis of Parkinson's disease and dementia with Lewy bodies.

9 Feb 2018

New FluChip-8G technology could aid in pandemic preparedness

InDevR Inc., a Boulder-based analytical technology and life science company, today announced plans to launch a Research Use Only version of their FluChip-8G technology to aid in pandemic preparedness.

6 Feb 2018

Cannabis Quality and Contamination Testing

Dr. Bob Clifford has published and presented over 125 papers in the fields of food, pharmaceutical, environmental, energy, geology, material science, photonics, and cannabis. However, his true love is in food. After graduating with his Ph.D., he left his job with the FDA for Shimadzu where he has worked for the last 26 years.

From Pittcon 5 Feb 2018

New organ-on-a-chip technology provides simple setting to study blood vessel formation

Researchers at the Institute of Industrial Science, the University of Tokyo, CNRS and INSERM, report a new organ-on-a-chip technology for the study of blood vessel formation and drugs targeting this event.

31 Jan 2018

Eagle Biosciences launches novel Intact FGF23 ELISA Assay Kit

Eagle Biosciences, Inc. is proud to announce the launch of a new assay, MedFrontier FGF23 (Human Intact FGF23) ELISA Assay Kit. This assay was developed and manufactured by Kyowa Medex Co., Ltd from Tokyo, Japan.

27 Jan 2018

Leading medical societies update molecular testing guideline for lung cancer

Rapid advancements in the molecular diagnostic testing of lung cancer have led to new treatments and greater hope for patients battling lung cancer, the most common cause of cancer death worldwide.

24 Jan 2018

Study shows value of occupational therapy in the lives of young adults with diabetes

New results from a University of Southern California-led research study demonstrates the distinct value of occupational therapy for improving the health and quality of life of young adults living with diabetes.

22 Jan 2018

Researchers develop single blood test that screens for 8 cancer types

Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

19 Jan 2018

Scientists identify protein biomarkers to track patients with Hutchinson-Gilford progeria syndrome

Hutchinson-Gilford progeria syndrome (HGPS) is an extremely rare fatal genetic disorder which causes sufferers to age prematurely.

19 Jan 2018

New high-sensitivity blood tests could aid faster diagnosis and treatment for heart attack

When diagnosing a heart attack, accuracy and timing are everything. A new test designed to better measure levels of troponin, a protein released when the heart muscle is damaged, could help emergency department physicians provide faster diagnosis and appropriate treatment.

16 Jan 2018

New cholesterol calculation method could eliminate need for routine fasting

In a direct comparison study, Johns Hopkins researchers have added to evidence that a newer method of calculating so-called "bad cholesterol" levels in the blood is more accurate than the older method in people who did not fast before blood was drawn.

2 Jan 2018

Researchers develop more accurate method to gauge incidence of HIV infections

Researchers at the Duke Human Vaccine Institute have led an effort to develop a more accurate way to gauge the incidence of HIV infections in large populations, which will improve research and prevention strategies worldwide.

21 Dec 2017

Scientists develop test to predict treatment outcomes in patients with childhood leukemia

UC San Francisco physician-scientists have developed a test that can predict how patients with juvenile myelomonocytic leukemia (JMML) will respond to treatment, and may also be able to identify patients who are likely to recover spontaneously with little to no treatment.

19 Dec 2017

A guide to Severe Combined Immunodeficiency Disease, review released

A new review published today in the Canadian Medical Association Journal provides guidance on Severe Combined Immunodeficiency Disease (SCID), a deadly and rare disease that is potentially curable if detected early.

18 Dec 2017

New review provides guidance to doctors who may treat infants with ‘bubble boy disease’

A new review provides guidance on a deadly, but rare, disease that is potentially curable if identified early. Severe combined immunodeficiency disease (SCID), known as the "bubble boy disease" in the 1970s, is treatable with a stem cell transplant, gene therapy and other treatments if identified at birth or soon after.